[go: up one dir, main page]

RU2003103117A - MEANS FOR TREATMENT OF INFLAMMATORY DISEASES OF PERIODONTAL - Google Patents

MEANS FOR TREATMENT OF INFLAMMATORY DISEASES OF PERIODONTAL

Info

Publication number
RU2003103117A
RU2003103117A RU2003103117/15A RU2003103117A RU2003103117A RU 2003103117 A RU2003103117 A RU 2003103117A RU 2003103117/15 A RU2003103117/15 A RU 2003103117/15A RU 2003103117 A RU2003103117 A RU 2003103117A RU 2003103117 A RU2003103117 A RU 2003103117A
Authority
RU
Russia
Prior art keywords
periodontal
treatment
inflammatory diseases
oil
eugenol
Prior art date
Application number
RU2003103117/15A
Other languages
Russian (ru)
Other versions
RU2228168C1 (en
Inventor
Мария Дмитриевна Дулькис
Лидия Анатольевна Брагинская
Original Assignee
Мария Дмитриевна Дулькис
Filing date
Publication date
Application filed by Мария Дмитриевна Дулькис filed Critical Мария Дмитриевна Дулькис
Priority to RU2003103117/15A priority Critical patent/RU2228168C1/en
Priority claimed from RU2003103117/15A external-priority patent/RU2228168C1/en
Application granted granted Critical
Publication of RU2228168C1 publication Critical patent/RU2228168C1/en
Publication of RU2003103117A publication Critical patent/RU2003103117A/en

Links

Claims (1)

Средство для лечения воспалительных заболеваний пародонта и слизистых оболочек полости рта, характеризующееся тем, что оно содержит тимол, фенил-салицилат, эвгенол, масло гвоздичное, масло шалфея, масло мяты, натрия фторид и вспомогательные вещества при следующем содержании компонентов, г:An agent for the treatment of inflammatory diseases of periodontal and oral mucous membranes, characterized in that it contains thymol, phenyl salicylate, eugenol, clove oil, sage oil, peppermint oil, sodium fluoride and excipients with the following components, g: Тимол 0,30-0,45Thymol 0.30-0.45 Фенилсалицилат 0,40-0,60Phenyl Salicylate 0.40-0.60 Эвгенол 0,23-0,27Eugenol 0.23-0.27 Масло гвоздичное 0,23-0,27Clove oil 0.23-0.27 Масло шалфея 0,45-0,55Sage Oil 0.45-0.55 Масло мяты 0,45-0,55Peppermint Oil 0.45-0.55 Натрия фторид 0,01-0,02Sodium Fluoride 0.01-0.02 Вспомогательные вещества До 100 гExcipients Up to 100 g
RU2003103117/15A 2003-02-05 2003-02-05 Agent for treatment of parodontium inflammatory diseases RU2228168C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003103117/15A RU2228168C1 (en) 2003-02-05 2003-02-05 Agent for treatment of parodontium inflammatory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003103117/15A RU2228168C1 (en) 2003-02-05 2003-02-05 Agent for treatment of parodontium inflammatory diseases

Publications (2)

Publication Number Publication Date
RU2228168C1 RU2228168C1 (en) 2004-05-10
RU2003103117A true RU2003103117A (en) 2004-08-20

Family

ID=32679467

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003103117/15A RU2228168C1 (en) 2003-02-05 2003-02-05 Agent for treatment of parodontium inflammatory diseases

Country Status (1)

Country Link
RU (1) RU2228168C1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2303455C1 (en) * 2005-12-22 2007-07-27 Наталья Васильевна Курякина Method for treating and preventing oral mucous membrane and periodontium diseases
WO2011036048A1 (en) 2009-09-24 2011-03-31 Unilever Nv Disinfecting agent comprising eugenol, terpineol and thymol
RU2416420C1 (en) * 2009-12-22 2011-04-20 Государственное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М.Сеченова Министерства здравоохранения и социального развития (ГОУ ВПО Первый МГМУ им. И.М.Сеченова Минздравсоцразвития России) Agent for treatment and prevention of periodontium and mouth mucosa diseases
BR112013013085B1 (en) 2010-12-07 2018-02-14 Unilever N.V. Oral Care Composition, Mouth Rinse, Toothpaste, Toothpaste, Method for Disinfecting Oral Cavity and Use of a Composition
IN2014MN00808A (en) 2011-11-03 2015-09-04 Unilever Plc
EP3485899A4 (en) 2017-09-25 2020-05-20 Georgy Georgievich Chumburidze Thermostable composition with antiviral and antibacterial activity and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2006223C1 (en) * 1992-12-28 1994-01-30 Научно-производственная и внедренческая фирма "Юнитекс" Composition for oral cavity diseases prophylaxis
RU2006222C1 (en) * 1992-12-28 1994-01-30 Товарищество с ограниченной ответственностью "Фиталон" Composition for prophylaxis of parodondium tissues and oral cavity mucous membrane diseases
RU2147223C1 (en) * 1997-07-29 2000-04-10 Куркин Владимир Александрович Agent for treatment of parodontium disease and method of its preparing
RU2160585C1 (en) * 1999-11-17 2000-12-20 Зао "Оргполимерсинтез" Composition for preventing oral cavity diseases
RU2158125C1 (en) * 1999-11-17 2000-10-27 Санкт-Петербургская медицинская академия последипломного образования Composition for preventing and treating diseases of periodontium and oral cavity mucosa

Similar Documents

Publication Publication Date Title
CL2007001918A1 (en) SUBSTITUTED HETEROARILY DERIVATIVE COMPOUNDS; METHOD FOR THE PREPARATION OF COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, DEPRESSION, ALZHEIMER'S DISEASE AND HYPERTENSION BETWEEN OTHERS.
CY1105082T1 (en) USE OF FLIVANSEPIN IN THE TREATMENT OF SEXUAL DESIRE DISORDERS
MXPA05012350A (en) Rage antagonists as agents to reverse amyloidosis and diseases associated therewith.
BRPI0311275A2 (en) "stable fenofibrate compositions for oral administration as well as use thereof"
CL2008000894A1 (en) Oral care composition comprising a basic amino acid in free or salt form, a soluble fluoride salt, a calcium salt of an organic acid; use in the treatment of demineralized teeth and enamel lesions of a subject's teeth.
JP2005503322A5 (en)
EA200300628A1 (en) CONNECTIONS SPECIFIC TO Adenosine A, A And Arecceptor, And Their Use
EP1539122A4 (en) PHARMACEUTICAL COMPOSITIONS OF AQUEOUS 2,6-DIISOPROPYLPHENOL
CL2007001917A1 (en) COMPOUNDS DERIVED FROM SIPROCICLIC AZAINDOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, CONDITIONS OF PANIC, DEPRESSION, EVIL OF ALZHEIMER, MIGRANA, AMONG OTHERS.
CY1108992T1 (en) USE OF HYALURONIC ACID FOR PREPARATION OF COMPOSITIONS FOR THE THERAPEUTIC TREATMENT OF ORAL TRAUMATIC DISEASES
CL2004000551A1 (en) COMPOUNDS DERIVED FROM TRIAZOL SUBSTITUTED WITH BIARILO, ITS SALTS, BLOCKERS OF THE SODIUM CHANNEL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE IN THE TREATMENT OR PREVENTION OF PAIN.
CY1113116T1 (en) Substituted 4-Aminocyclohexanols
BR0311189A (en) Flibanserin polymorphic a-containing pharmaceutical compositions
DE602004016403D1 (en) Topical pharmaceutical compositions containing active natural ingredients for the prevention and treatment of mucosal inflammatory processes
RU2003103117A (en) MEANS FOR TREATMENT OF INFLAMMATORY DISEASES OF PERIODONTAL
NO20054798D0 (en) Processed fat preparation for the prevention / improvement of lifestyle-related diseases
EA200600176A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ASCORBIC ACID FOR THE TREATMENT OF FUNGAL SUPERINFECTIONS AND FUNGAL RECURRENTS
NO20054180D0 (en) Treatment of bacterial diseases of the respiratory tract by local administration of fluoroquinolones
DK1648440T3 (en) Semi-solid formulations for the oral administration of taxoids
RU2003103881A (en) DENTAL GEL FOR TREATMENT OF INFLAMMATORY DISEASES OF THE ORAL CAVITY
RU2002121636A (en) INDOLA DERIVATIVES AS ANCRONISTS OF MCP-1 RECEPTORS
RU2004101018A (en) Salts of Zinc and Halocarboxylic Acids of the Aliphatic Series for the Treatment of Skin Neoplasms and Visible Mucous Covers
RU2006109966A (en) YANTASTIM-S DRUG FOR THERAPY AND PREVENTION OF ANIMAL INFECTIOUS DISEASES
MXPA03009484A (en) PREVENTIVE / REMEDY AGENT FOR INFLAMMATORY DISEASES IN THE MUCOSA OF THE ORAL CAVITY AND THE SIMILAR.
RU2003116948A (en) DENTAL PASTE COMPOSITION